AngioDynamics (ANGO) Tops Q4 EPS by 11c, provides guidance
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $15.75 -0.44%
Financial Fact:
Income tax provision: 1.6M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Income tax provision: 1.6M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
AngioDynamics (NASDAQ: ANGO) reported Q4 EPS of ($0.05), $0.10 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $70.98 million versus the consensus estimate of $70.9 million.
GUIDANCE:
AngioDynamics sees FY2025 EPS of ($0.38)-($0.42), versus the consensus of ($0.52). AngioDynamics sees FY2025 revenue of $282-288 million, versus the consensus of $292.7 million.
For earnings history and earnings-related data on AngioDynamics (ANGO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- loanDepot receives NYSE non-compliance notice over stock price
- Cytek faces $56M damages award in Beckman Coulter patent case
- Silexion Therapeutics faces Nasdaq delisting over equity shortfall
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
